FDA Self-Selection Study Guidance Calls For Complex Questions
This article was originally published in The Tan Sheet
Executive Summary
Final guidance on Rx-to-OTC self-selection studies makes space for investigation of novel switches under NSURE by recommending researchers ask complex questions that “involve a higher level of understanding” of multiple label elements at once.
You may also be interested in...
In Switch Label Studies, FDA Carefully Reads Data On Low-Literacy Consumers
Switch sponsors should include low-literacy subjects in label comprehension studies to address the “real risk” of taking an Rx product OTC, says a CDER Division of Nonprescription Drug Products social scientist. Self-selection studies similarly should include at-risk consumer populations.
In Switch Label Studies, FDA Carefully Reads Data On Low-Literacy Consumers
Switch sponsors should include low-literacy subjects in label comprehension studies to address the “real risk” of taking an Rx product OTC, says a CDER Division of Nonprescription Drug Products social scientist. Self-selection studies similarly should include at-risk consumer populations.
FDA Expects OTC Switch Self-Selection Studies To Probe Consumer Thinking
A draft guidance on designing self-selection studies in support of Rx-to-OTC switches reflects FDA’s interest in drilling down for greater insight into consumers’ thought processes.